Old Web
English
Sign In
Acemap
>
authorDetail
>
Zsolt Szijgyarto
Zsolt Szijgyarto
Institute of Cancer Research
Medicine
Oncology
Internal medicine
Fractionation
Radiation therapy
4
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
2021
Richard Buus
Zsolt Szijgyarto
Eugene F. Schuster
Hui Xiao
BP Haynes
Ivana Sestak
Jack Cuzick
Laia Paré
Elia Seguí
Nuria Chic
Aleix Prat
Mitch Dowsett
Maggie C.U. Cheang
Show All
Source
Cite
Save
Citations (2)
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)—PathIES
2019
Breast Cancer Research and Treatment
Zsolt Szijgyarto
Koen D. Flach
Mark Opdam
Carlo Palmieri
Sabine C. Linn
Jelle Wesseling
Simak Ali
Judith M. Bliss
Maggie C.U. Cheang
Wilbert Zwart
R. Charles Coombes
Show All
Source
Cite
Save
Citations (1)
Assessment of Ki67 in relation to radiotherapy (RT) fractionation and prognosis in the CHHiP (CRUK/06/016) trial.
2018
Journal of Clinical Oncology
Anna Wilkins
Barry A. Gusterson
Zsolt Szijgyarto
J.S. Haviland
Clare Griffin
Christine Stuttle
Frances Daley
Catherine M. Corbishley
David P. Dearnaley
Emma Hall
Navita Somaiah
Show All
Source
Cite
Save
Citations (0)
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer
2018
International Journal of Radiation Oncology Biology Physics
Anna Wilkins
Barry Gusterson
Zsolt Szijgyarto
J.S. Haviland
Clare Griffin
Christine Stuttle
Frances Daley
Catherine M. Corbishley
David P. Dearnaley
Emma Hall
Navita Somaiah
CHHiP Trial Investigators
Show All
Source
Cite
Save
Citations (5)
1